ENYO Pharma prend part de mani\u00e8re active \u00e0 la recherche contre l’H\u00e9patite B avec le d\u00e9veloppement de son agoniste de FXR EYP001 et soutien la recherche dans ce domaine en devenant l’un des sponsors de “Hep B Foundation” qui est “une organisation nationale non-lucrative d\u00e9di\u00e9e \u00e0 la d\u00e9couverte d’un traitement pour gu\u00e9rir et am\u00e9liorer la qualit\u00e9 de vie de ceux affect\u00e9s par l’h\u00e9patite B de par le monde”. <\/p>\n","protected":false},"excerpt":{"rendered":"
ENYO Pharma prend part de mani\u00e8re active \u00e0 la recherche contre l’H\u00e9patite B avec le d\u00e9veloppement de son agoniste de FXR EYP001 et soutien la recherche dans ce domaine en devenant l’un des sponsors de “Hep B Foundation” qui est “une organisation nationale non-lucrative d\u00e9di\u00e9e \u00e0 la d\u00e9couverte d’un traitement pour gu\u00e9rir et am\u00e9liorer la qualit\u00e9 de vie de ceux affect\u00e9s par l’h\u00e9patite B de par le monde”. <\/p>\n
Lire la suite »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-3089","post","type-post","status-publish","format-standard","hentry","category-latest-news-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"Br\u00e8ves<\/a>","rttpg_excerpt":"ENYO Pharma prend part de mani\u00e8re active \u00e0 la recherche contre l’H\u00e9patite B avec le d\u00e9veloppement de son agoniste de FXR EYP001 et soutien la recherche dans ce domaine en devenant l’un des sponsors de “Hep B Foundation” qui est “une organisation nationale non-lucrative d\u00e9di\u00e9e \u00e0 la d\u00e9couverte d’un traitement pour gu\u00e9rir et am\u00e9liorer la…","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3089"}],"version-history":[{"count":1,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3089\/revisions"}],"predecessor-version":[{"id":3090,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3089\/revisions\/3090"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}